Wendell Wierenga insider trades

Open-market stock purchases and sales by Wendell Wierenga, Director at Cytokinetics Inc, from SEC Form 4 filings since Aug 17, 2021.

Recent trades

DateStockTradeValue
Oct 16, 2026CYTK Cytokinetics IncBought (not open market)$6.2K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$9.9M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$772K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$772K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.2M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$545K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$478K
Jul 15, 2026CYTK Cytokinetics IncBought (not open market)$6.2K
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 5, 2026CYTK Cytokinetics IncSold$302K
May 5, 2026CYTK Cytokinetics IncBought (not open market)—
Apr 15, 2026CYTK Cytokinetics IncBought (not open market)$6.2K
Jan 15, 2026CYTK Cytokinetics IncBought (not open market)$6.2K
Jan 2, 2026DRMA Dermata Therapeutics, IncBought (not open market)—
Dec 22, 2025CYTK Cytokinetics IncSold$1.3M
Dec 22, 2025CYTK Cytokinetics IncBought (not open market)—
Oct 27, 2025CYTK Cytokinetics IncSold$257K
Oct 27, 2025CYTK Cytokinetics IncBought (not open market)—

Companies traded

  • CYTK Cytokinetics Inc: 3 sales, last Oct 16, 2026
  • CRNX Crinetics Pharmaceuticals, Inc: other filings, last Sep 1, 2026
  • DRMA Dermata Therapeutics, Inc: other filings, last Jan 2, 2026

Get free alerts when Wendell Wierenga files a new trade →